Skip to main content
OpenTrials

Clinical trial condition

Hyperlipidemias

Explore clinical trials studying Hyperlipidemias. Study availability and eligibility vary by location and protocol.

1,239 public trials 92 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipidemias trial results

Recruiting

A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia

NCT07269210

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Synexus Clinical Research US, Inc./Orange Grove Family Practice Tucson, Arizona, United States
  • National Heart Institute Beverly Hills, California, United States
  • Ark Clinical Research Long Beach, California, United States
  • Catalina Research Institute, LLC Montclair, California, United States
View all 41 locations
View Trial Details
Recruiting

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

NCT06909565

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +13 more
Locations
  • Advanced Cardiovascular LLC Alexander City, Alabama, United States
  • Cardiology, PC Birmingham, Alabama, United States
  • Heart Center Research, LLC Huntsville, Alabama, United States
  • Cardiology Associates Research Group Jonesboro, Arkansas, United States
View all 139 locations
View Trial Details
Recruiting

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

NCT06880770

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Research Site Los Angeles, California, United States
  • Clinical Research Site 4 Santa Clarita, California, United States
  • Research Site New Haven, Connecticut, United States
  • Clinical Research Site 6 Springfield, Illinois, United States
View all 140 locations
View Trial Details
Recruiting

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

NCT05682378

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Excel Medical Clinical Trials LLC Boca Raton, Florida, United States
  • Icahn School of Med at Mt Sinai New York, United States
  • Cincinnati Childrens Hospital MC Cincinnati, Ohio, United States
  • Childrens Hosp Pittsburgh UPMC Pittsburgh, Pennsylvania, United States
View all 52 locations
View Trial Details
Recruiting

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

NCT07491172

Conditions
Cardiovascular, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +20 more
Locations
  • Integrity Clinical Research Hialeah, Florida, United States
  • Jacksonville Center for Clinical Research Jacksonville, Florida, United States
  • Flourish Orlando Orlando, Florida, United States
  • United Medical Research Port Orange, Florida, United States
View all 17 locations
View Trial Details
Recruiting

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

NCT07619131

Conditions
Dyslipidemias, Hypercholesterolaemia, Hypercholesterolemia, +4 more
Locations
  • Research Site Dothan, Alabama, United States
  • Research Site Chandler, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Huntington Beach, California, United States
View all 152 locations
View Trial Details

Related conditions